课题基金 / 基金详情

Gene expression of cell diferenciation related factors of respiratory epithelium and its roll in the mucosal pathology of rhino sinusitis

Gene expression of cell diferenciation related factors of respiratory epithelium and its roll in the mucosal pathology of rhino sinusitis
鼻窦炎黏膜病理中呼吸道上皮及其卷曲细胞分化相关因子基因表达
批准号:
09671755
负责人:
MATSUNE Shoji
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

MATSUNE Shoji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Genetic investigation : Several bands that appeared on the collagen gel following floating were extracted by the differential display method. The protein volume expression of 5 of the 25 sequenced bands was determined before and after floating by Northern blotting. Protein expression did not differ between the two measurement period. This lack of difference was attributed to the high frequency of false positive results using Northern blotting.Morphological confirmation of cell differentiation : Expression of cytokeratin the cultured cells was examined chronologically by an immunohistochemical technique using anti-cytokeratin 8, 13 and 14 monochronal antibodies, although the cultured cells showed no positive findings before floating, this analysis showed a gradual increase in positive staining after floating in the following pattern ; anti-cytokeratin 8 was positively stained from the middle to apical layer of the cultured cells and anti-cytokeratin 13 was positively stained only in the middle layer and anti-cytokeratin 14 was positively stained in the basal layer.Detection of ciliogenesis-specific substance : Several monochronal antibodies were produced, of which RPCS3a, the most eligible candidate specific to ciliogenesis, was characterized. RPCS3a was expressed in the cultured cell from the 3rd day after floating according to cellular ELISA.On the 10th day, RPCS3a was expressed most strongly, and many cultured cells contained secretory vesicles at their apical site as well as numerous centrioles indicating to be preciliated cells. ELISA revealed that RPCS3a is specific to the a sort of fucosylated carbohydrate H type 3. The expressed volume of H type 3 recognized by RPCS3a appears to reflect the stage of ciliogenesis. Based on the present data, we consider H type 3 to be a relativity specific markers of ciliogenesis and thus may provide a useful tool to clarify the mechanisms of ciliogenesis.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
宮之原郁代: "YAMIKカテーテルを用いた副鼻腔炎貯留液の細菌学的検討" 耳鼻咽喉科展望. 40(補2). 141-145 (1997)
Ikuyo Miyanohara:“使用 YAMIK 导管进行鼻窦炎液体的细菌学研究”《耳鼻喉科展望》40(补充 2)(1997 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
大山 勝: "YAMIKカテーテル法の臨床的検討" 耳鼻臨床. 90(3). 361-375 (1997)
Masaru Oyama:“YAMIK 导管插入术的临床回顾”Otorhinolaryngology 90(3) (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kouji Deguchi: "Fucosylated(H type3)Antigen in Mucociliary Culture is Expressed Mainly in the Ciliated Cell Lineage." 鹿児島大学医学雑誌. (in press).
Kouji Deguchi:“粘膜纤毛培养物中的岩藻糖基化(H 型)抗原主要在纤毛细胞谱系中表达。”(鹿儿岛大学医学杂志)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
17
    Gut microbiome Candida as a new pathophysiological causative factor of intractable eosinophilic chronic rhinosinusitis
    • 批准号:
      19K09917
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2019
    • 负责人:
      MATSUNE Shoji
    • 依托单位:
    New therapy for refractory chronic sinusitis in application with priming effect of macrolide on steroid therapy
    Examination of the gene therapy for OME using Decoy oligo.
    • 批准号:
      15591823
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2003
    • 负责人:
      MATSUNE Shoji
    • 依托单位:
    Vascular endotherial growth factor )VEGF) in paranasal sinusitis and allergic rhinitis
    • 批准号:
      11671694
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      1999
    • 负责人:
      MATSUNE Shoji
    • 依托单位:
    国内基金
    海外基金
    肝癌细胞膜蛋白cytokeratin-1用于肝癌在体分子显像和靶向治疗的相关研究
    • 批准号:
      81172075
    • 项目类别:
      面上项目
    • 资助金额:
      14.0万元
    • 批准年份:
      2011
    • 负责人:
      陈立波
    • 依托单位: